Recap: Thermo Fisher Scientific Q2 Earnings

Shares of Thermo Fisher Scientific TMO rose 0.7% after the company reported Q2 results.

Quarterly Results

Earnings per share increased 27.96% over the past year to $3.89, which beat the estimate of $2.84.

Revenue of $6,917,000,000 higher by 9.52% from the same period last year, which beat the estimate of $6,130,000,000.

Guidance

Thermo Fisher Scientific hasn't issued any earnings guidance for the time being.

Revenue guidance hasn't been issued by the company for now.

Conference Call Details

Date: Jul 22, 2020

Time: 08:30 AM

ET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Fir.thermofisher.com%2Finvestors%2Fnews-and-events%2Fwebcasts-and-presentations%2Fevent-details%2F2020%2FQ2-2020-Thermo-Fisher-Scientific-Earnings-Conference-Call%2Fdefault.aspx&eventid=2386116&sessionid=1&key=F32A33446F3D8CB429B82174063B1E35&regTag=&sourcepage=register

Recent Stock Performance

Company's 52-week high was at $409.69

52-week low: $250.21

Price action over last quarter: Up 25.77%

Company Description

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments (revenue figures include some cross-segment revenue): analytical technologies (22% of sales); specialty diagnostic products (15%); life science solutions (27%); and lab products and services (42%).